vTv Therapeutics (VTVT) Profit After Tax (2014 - 2026)
vTv Therapeutics recorded quarterly Profit After Tax of $24.1 million in Q1 2026, up 438.11% quarter-over-quarter from -$7.1 million in Q4 2025, and up 488.19% year-over-year from $4.1 million in Q1 2025.
vTv Therapeutics' Profit After Tax history runs 13 years deep, the most recent figure standing at $24.1 million for Q1 2026.
- In Q1 2026, Profit After Tax rose 488.19% year-over-year to $24.1 million; the TTM figure through Mar 2026 stood at $605000.0 (up 102.88% YoY), while the FY2025 annual figure was -$27.0 million, down 46.11% from the prior year.
- Profit After Tax came in at $24.1 million for Q1 2026 at vTv Therapeutics, up from -$7.1 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $24.1 million in Q1 2026 to a low of -$10.3 million in Q3 2025.
- A 5-year average of -$4.2 million and a median of -$6.0 million in 2024 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax sank 572.86% in 2022 and surged 488.19% in 2026, its largest moves.
- vTv Therapeutics' Profit After Tax stood at -$4.7 million in 2022, then climbed by 6.41% to -$4.4 million in 2023, then rose by 18.17% to -$3.6 million in 2024, then sank by 96.42% to -$7.1 million in 2025, then surged by 438.11% to $24.1 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered $24.1 million, -$7.1 million, and -$10.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 205.99 Mn |
| 10 | vTv Therapeutics | 413.85 Mn | 413.85 Mn | - | 24.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.13 Mn |
| Dec 31, 2025 | -7.14 Mn |
| Sep 30, 2025 | -10.35 Mn |
| Jun 30, 2025 | -6.05 Mn |
| Mar 31, 2025 | -6.22 Mn |
| Dec 31, 2024 | -3.63 Mn |
| Sep 30, 2024 | -4.78 Mn |
| Jun 30, 2024 | -6.41 Mn |
| Mar 31, 2024 | -6.02 Mn |
| Dec 31, 2023 | -4.44 Mn |
| Sep 30, 2023 | -8.54 Mn |
| Jun 30, 2023 | -7.21 Mn |
| Mar 31, 2023 | -4.50 Mn |
| Dec 31, 2022 | -4.75 Mn |
| Sep 30, 2022 | -4.26 Mn |
| Jun 30, 2022 | -4.09 Mn |
| Mar 31, 2022 | -7.01 Mn |
| Dec 31, 2021 | -9.48 Mn |
| Sep 30, 2021 | -1.09 Mn |
| Jun 30, 2021 | -608,000.00 |
| Mar 31, 2021 | -5.94 Mn |
| Dec 31, 2020 | 1.13 Mn |
| Sep 30, 2020 | -2.25 Mn |
| Jun 30, 2020 | -3.37 Mn |
| Mar 31, 2020 | -7.17 Mn |
| Dec 31, 2019 | -4.40 Mn |
| Sep 30, 2019 | -5.96 Mn |
| Jun 30, 2019 | -5.11 Mn |
| Mar 31, 2019 | -2.16 Mn |
| Dec 31, 2018 | -1.09 Mn |
| Sep 30, 2018 | -1.96 Mn |
| Jun 30, 2018 | -9.60 Mn |
| Mar 31, 2018 | -9.96 Mn |
| Dec 31, 2017 | -14.59 Mn |
| Sep 30, 2017 | -3.65 Mn |
| Jun 30, 2017 | -13.41 Mn |
| Mar 31, 2017 | -4.22 Mn |
| Dec 31, 2016 | -13.71 Mn |
| Sep 30, 2016 | -13.51 Mn |
| Jun 30, 2016 | -14.62 Mn |
| Mar 31, 2016 | -3.85 Mn |
| Dec 31, 2015 | -3.17 Mn |
| Sep 30, 2015 | -9.82 Mn |
| Jun 30, 2015 | -10.41 Mn |
| Mar 31, 2015 | -9.81 Mn |
| Dec 31, 2014 | -7.72 Mn |
| Sep 30, 2014 | -5.87 Mn |
| Jun 30, 2014 | -7.40 Mn |